Compare GKOS & AXTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GKOS | AXTA |
|---|---|---|
| Founded | 1998 | 1910 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Paints/Coatings |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4B | 6.2B |
| IPO Year | 2015 | 2014 |
| Metric | GKOS | AXTA |
|---|---|---|
| Price | $109.19 | $30.89 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 14 |
| Target Price | ★ $123.62 | $37.00 |
| AVG Volume (30 Days) | 846.3K | ★ 5.0M |
| Earning Date | 10-29-2025 | 10-28-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 40.67 |
| EPS | N/A | ★ 2.09 |
| Revenue | $469,820,000.00 | ★ $5,166,000,000.00 |
| Revenue This Year | $31.15 | N/A |
| Revenue Next Year | $24.15 | $2.22 |
| P/E Ratio | ★ N/A | $14.78 |
| Revenue Growth | ★ 30.38 | N/A |
| 52 Week Low | $73.16 | $26.28 |
| 52 Week High | $163.71 | $39.19 |
| Indicator | GKOS | AXTA |
|---|---|---|
| Relative Strength Index (RSI) | 70.89 | 63.62 |
| Support Level | $105.88 | $28.09 |
| Resistance Level | $110.87 | $30.52 |
| Average True Range (ATR) | 3.39 | 0.81 |
| MACD | -0.04 | 0.10 |
| Stochastic Oscillator | 80.77 | 91.11 |
Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.
Axalta Coating Systems Ltd is a manufacturer, marketer and distributor of high-performance coatings systems. It operates in two segments, The Performance Coatings segment provides liquid and powder coatings solutions to a fragmented and local customer base. Its end markets include refinish and industrial. The Mobility Coatings segment relates to the provision of coating technologies to original equipment manufacturers of light and commercial vehicles. The company operates in the geographic areas of North America, EMEA countries, Asia-Pacific, and Latin America.